Antiviral Potential of Coconut (Cocos nucifera L.) Oil and COVID-19
KRISHI: Publication and Data Inventory Repository
View Archive InfoField | Value | |
Title |
Antiviral Potential of Coconut (Cocos nucifera L.) Oil and COVID-19
Not Available |
|
Creator |
S.V. Ramesh, R. Pandiselvam, K.B. Hebbar, M.R. Manikantan, P.P. Shameena Beegum, Shelly Praveen, N.U. Sruthi
|
|
Subject |
Antiviral therapy, immune-modulation, medium-chain fatty acids, lauric acid, SARS-CoV-2, Cocos nucifera L
|
|
Description |
Not Available
Background: COVID-19 caused by the novel SARS Coronavirus-2 (SARS-CoV-2) is causing serious problems in the global public health sphere. In the absence of a powerful antiviral treatment, the exploration of plant-based products with antiviral potential has gained interest. Scope and Approach: This commentary presents the prospects of utilizing coconut oil directly or its derivatives such as monolaurin in treating COVID-19 with a special emphasis on their biochemical characteristics features. The potential pitfalls therein and way forward are also highlighted. Key findings and conclusions: There are enough research-backed evidences to demonstrate the antiviral capabilities of coconut oil and monolaurin. The possibility of developing a medium-chain fatty acidbased nasal spray as a prophylactic or therapeutic is also discussed. Nevertheless, the potential impediments in devising suitable therapeutic models to treat SARS-CoV-2, are presented. Not Available |
|
Date |
2021-07-30T04:56:27Z
2021-07-30T04:56:27Z 2021-05-31 |
|
Type |
Article
|
|
Identifier |
Not Available
Not Available http://krishi.icar.gov.in/jspui/handle/123456789/51360 |
|
Language |
English
|
|
Relation |
Not Available;
|
|
Publisher |
Not Available
|
|